We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$1.67B
1-Year Est. Return
7.53%
This Fund
S&P 500
This Quarter
Est. Return
+6.31%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$4.48B
AUM Growth
-$217M
(-4.6%)
Cap. Flow
-$417M
Cap. Flow
% of AUM
-9.3%
Top 10 Holdings %
Top 10 Hldgs %
80.33%
Holding
67
New
7
Increased
4
Reduced
20
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$104M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
+$29.3M |
| 3 |
Roivant Sciences
ROIV
|
+$21.8M |
| 4 |
Neumora Therapeutics
NMRA
|
+$21.2M |
| 5 |
Sagimet Biosciences
SGMT
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$113M |
| 2 |
KE Holdings
BEKE
|
+$81.9M |
| 3 |
JD.com
JD
|
+$76.4M |
| 4 |
Pinduoduo
PDD
|
+$70.8M |
| 5 |
Huazhu Hotels Group
HTHT
|
+$58.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.88% |
| 2 | Consumer Discretionary | 31.35% |
| 3 | Technology | 13.19% |
| 4 | Real Estate | 10.63% |
| 5 | Communication Services | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
1
BeOne Medicines Ltd
ONC
$34B
| $931M | 20.79% |
5,176,906
| – | – |
|
|
2
Pinduoduo
PDD
$125B
| $721M | 16.1% |
7,350,847
-821,400
| -10% | -$70.8M |
|
|
3
KE Holdings
BEKE
$17.6B
| $476M | 10.63% |
30,665,445
-5,157,209
| -14% | -$81.9M |
|
4
Legend Biotech
LEGN
$3.64B
| $432M | 9.65% |
6,436,533
| – | – |
|
5
Microsoft
MSFT
$2.93T
| $253M | 5.65% |
801,700
+42,400
| +6% | +$14M |
|
6
DoorDash
DASH
$84.6B
| $212M | 4.73% |
2,666,763
| – | – |
|
7
Salesforce
CRM
$155B
| $184M | 4.11% |
908,637
-163,900
| -15% | -$35.4M |
|
|
8
Alibaba
BABA
$275B
| $176M | 3.93% |
2,030,447
-1,232,080
| -38% | -$113M |
|
9
Take-Two Interactive
TTWO
$46.4B
| $110M | 2.45% |
783,000
| – | – |
|
|
10
Amazon
AMZN
$2.45T
| $102M | 2.28% |
802,000
+777,700
| +3,200% | +$104M |
|
|
11
Huazhu Hotels Group
HTHT
$13.3B
| $95.9M | 2.14% |
2,433,083
-1,381,222
| -36% | -$58.3M |
|
12
BridgeBio Pharma
BBIO
$16.5B
| $73.4M | 1.64% |
2,782,750
-210,697
| -7% | -$5.98M |
|
13
Baidu
BIDU
$35.5B
| $71.9M | 1.61% |
535,400
-17,953
| -3% | -$2.52M |
|
|
DQ
14
Daqo New Energy
DQ
$815M
| $61.7M | 1.38% |
2,037,000
| – | – |
|
|
ENFN
15
DELISTED
Enfusion, Inc.
ENFN
| $44.6M | 1% |
4,975,183
| – | – |
|
16
Coupang
CPNG
$27.4B
| $43.9M | 0.98% |
2,580,700
-237,400
| -8% | -$4.27M |
|
17
Cytek Biosciences
CTKB
$566M
| $36.7M | 0.82% |
6,657,030
| – | – |
|
|
YSG
18
Yatsen Holding
YSG
$311M
| $34.9M | 0.78% |
6,987,840
| – | – |
|
19
ZTO Express
ZTO
$18.3B
| $32.7M | 0.73% |
1,350,926
-1,146,488
| -46% | -$29.2M |
|
|
RYZB
20
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $31M | 0.69% |
+1,395,716
| New | +$29.3M |
|
21
Mondelez International
MDLZ
$84.1B
| $30.7M | 0.68% |
441,688
-82,100
| -16% | -$5.92M |
|
|
22
Roivant Sciences
ROIV
$23.8B
| $28.6M | 0.64% |
2,448,579
+1,925,118
| +368% | +$21.8M |
|
23
Full Truck Alliance
YMM
$9.88B
| $24.9M | 0.56% |
3,533,932
-1,692,487
| -32% | -$11.7M |
|
|
24
Neumora Therapeutics
NMRA
$306M
| $24M | 0.54% |
+1,699,313
| New | +$21.2M |
|
25
Danaher
DHR
$142B
| $21.2M | 0.47% |
96,444
| – | – |
|
Similar funds
TFS
GC
PA
LCI
JPM
NRI
CPO
JIP
HHLR Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, HHLR Advisors held 67 positions worth $4.48B, down 4.6% from $4.7B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
HHLR Advisors withdrew a net $417M in Q3 2023, closing 7 positions and reducing 20 holdings. Its most notable exit was Keurig Dr Pepper, an estimated $17.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, HHLR Advisors opened a new position in RayzeBio, Inc. Common Stock worth $31M.
- HHLR Advisors's largest Q3 2023 buy was RayzeBio, Inc. Common Stock: 1,395,716 shares worth $31M.
- HHLR Advisors added most to Amazon in Q3 2023, an estimated $104M increase.
- HHLR Advisors's biggest Q3 2023 reduction was Alibaba, cutting an estimated $113M.
- HHLR Advisors fully exited Keurig Dr Pepper in Q3 2023, selling an estimated $17.7M.
- HHLR Advisors's ten largest holdings make up 80% of its $4.48B portfolio in Q3 2023.
- HHLR Advisors opened 7 new positions and closed 7 in Q3 2023.
- HHLR Advisors's portfolio value fell 4.6% quarter-over-quarter to $4.48B.
Based on HHLR Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.